Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azasetron, (+-)-isomer
2. N-(1-azabicyclo(2.2.2)oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4 -dihydro-2h-1,4-benzoxazine-8-carboxamide Hydrochloride
3. Y 25130
4. Y-25130
1. Nazasetron
2. 123040-69-7
3. Azasetron [inn]
4. 123039-99-6
5. 77hc7urr9z
6. N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide
7. Azasetron (inn)
8. Ncgc00024563-02
9. Y-25130
10. Dsstox_cid_25651
11. Dsstox_rid_81029
12. Dsstox_gsid_45651
13. 2h-1,4-benzoxazine-8-carboxamide, N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-
14. Cas-123040-69-7
15. Seroton
16. (r)-azasetron
17. 6-chloro-4-methyl-3-oxo-n-(quinuclidin-3-yl)-3,4-dihydro-2h-benzo[b][1,4]oxazine-8-carboxamide
18. Azasetron [mi]
19. Biomol-nt_000105
20. Unii-77hc7urr9z
21. Azasetron [who-dd]
22. Schembl17190
23. Bpbio1_001397
24. Gtpl2285
25. Chembl1598608
26. Dtxsid7045651
27. Schembl13186328
28. Arazasetron, (+/-)-
29. Chebi:91712
30. Tox21 110906
31. Tox21_110906
32. Akos015964402
33. Tox21_110906_1
34. Sb18701
35. (+-)-6-chloro-3,4-dihydro-4-methyl-3-oxo-n-3-quinuclidinyl-2h-1,4-benzoxazine-8-carboxamide
36. (- )-6-chloro-3,4-dihydro-4-methyl-3-oxo-n-3-quinuclidinyl-2h-1,4-benzoxazine-8-carboxamide
37. Ncgc00024563-03
38. Ncgc00024563-04
39. Ncgc00024563-05
40. D07481
41. Ab00640014_08
42. 040a697
43. Q4832285
44. Brd-a44133049-001-01-5
45. Brd-a68360487-003-01-0
46. 6-chloro-3,4-dihydro-4-methyl-3-oxo-n-(3-quinuclidinyl)-2h-1,4-benzoxazine-8-carboxamide
47. 6-chloro-3,4-dihyro-4-methyl-3-oxo-n-(3-quinuclidinyl)-2h-1,4-benzoxazine-8-carboxamide
48. N-(1-azabicyclo[2.2.2]octan-8-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide
49. (+/-)-6-chloro-3,4-dihydro-4-methyl-3-oxo-n-3-quinuclidinyl-2h-1,4-benzoxazine-8-carboxamide
50. N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-4-methyl-3-oxo-3,4-dihydro-2h-1,4-benzoxazine-8-carboxamide
| Molecular Weight | 349.8 g/mol |
|---|---|
| Molecular Formula | C17H20ClN3O3 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 349.1193192 g/mol |
| Monoisotopic Mass | 349.1193192 g/mol |
| Topological Polar Surface Area | 61.9 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 523 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
ABOUT THIS PAGE
A Azasetron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azasetron, including repackagers and relabelers. The FDA regulates Azasetron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azasetron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Azasetron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Azasetron supplier is an individual or a company that provides Azasetron active pharmaceutical ingredient (API) or Azasetron finished formulations upon request. The Azasetron suppliers may include Azasetron API manufacturers, exporters, distributors and traders.
click here to find a list of Azasetron suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Azasetron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azasetron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azasetron GMP manufacturer or Azasetron GMP API supplier for your needs.
A Azasetron CoA (Certificate of Analysis) is a formal document that attests to Azasetron's compliance with Azasetron specifications and serves as a tool for batch-level quality control.
Azasetron CoA mostly includes findings from lab analyses of a specific batch. For each Azasetron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azasetron may be tested according to a variety of international standards, such as European Pharmacopoeia (Azasetron EP), Azasetron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azasetron USP).
LOOKING FOR A SUPPLIER?
